We are live on ! Find out more
RIA

RPG Investment Advisory Portfolio holdings

AUM $973M
1-Year Est. Return 39.93%
This Fund
S&P 500
This Quarter Est. Return
+1.65%
1 Year Est. Return
+39.93%
3 Year Est. Return
+154.97%
5 Year Est. Return
+194.44%
10 Year Est. Return
+462.18%
AUM
$425M
AUM Growth
-$2.52M
Cap. Flow
-$10.6M
Cap. Flow %
-2.49%
Top 10 Hldgs %
25.9%
Holding
301
New
12
Increased
53
Reduced
74
Closed
36

Top Buys

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$7.45M
2
BMY icon
Bristol-Myers Squibb
BMY
+$7.38M
3
ISRG icon
Intuitive Surgical
ISRG
+$5.08M
4
CVS icon
CVS Health
CVS
+$4.95M
5
XYZ
Block Inc
XYZ
+$4.48M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$6.56M
2
SBUX icon
Starbucks
SBUX
+$6.48M
3
TGT icon
Target
TGT
+$5.59M
4
AMBA icon
Ambarella
AMBA
+$5.4M
5
RMD icon
ResMed
RMD
+$5.08M

Sector Composition

Rank Sector Weight
1 Energy 10.77%
2 Technology 10.13%
3 Consumer Discretionary 10.11%
4 Healthcare 10.06%
5 Industrials 9.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
L icon
151
Loews
L
$23.7B
$18K ﹤0.01%
325
– –
RF icon
152
Regions Financial
RF
$27.2B
$18K ﹤0.01%
1,200
– –
XLP icon
153
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
$18K ﹤0.01%
305
-1,830
-86% -$105K
NWBI icon
154
Northwest Bancshares
NWBI
$2.34B
$16K ﹤0.01%
907
– –
STEW
155
SRH Total Return Fund
STEW
$1.8B
$16K ﹤0.01%
1,400
– –
TLRY icon
156
Tilray
TLRY
$602M
$16K ﹤0.01%
34
– –
RAD
157
DELISTED
Rite Aid Corporation
RAD
$16K ﹤0.01%
1,922
-1
-0.1% -$9
ALXN
158
DELISTED
Alexion Pharmaceuticals
ALXN
$16K ﹤0.01%
125
– –
ABT icon
159
Abbott
ABT
$183B
$14K ﹤0.01%
+164
New +$12.9K
ARLP icon
160
Alliance Resource Partners
ARLP
$3.27B
$14K ﹤0.01%
812
– –
WAB icon
161
Wabtec
WAB
$50B
$14K ﹤0.01%
185
-460
-71% -$32.6K
DIA icon
162
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$46.7B
$13K ﹤0.01%
49
– –
IYLD icon
163
iShares Morningstar Multi-Asset Income ETF
IYLD
$126M
$13K ﹤0.01%
529
+5
+1% +$123
KOMP icon
164
State Street SPDR S&P Kensho New Economies Composite ETF
KOMP
$2.74B
$13K ﹤0.01%
+400
New +$12.9K
IDXX icon
165
Idexx Laboratories
IDXX
$46.1B
$12K ﹤0.01%
45
– –
MXI icon
166
iShares Global Materials ETF
MXI
$358M
$12K ﹤0.01%
180
-60
-25% -$3.86K
PRLB icon
167
Protolabs
PRLB
$2.16B
$12K ﹤0.01%
100
– –
TM icon
168
Toyota
TM
$220B
$12K ﹤0.01%
95
– –
XLY icon
169
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23B
$12K ﹤0.01%
200
– –
MIC
170
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$12K ﹤0.01%
290
– –
IQ icon
171
iQIYI
IQ
$1.24B
$11K ﹤0.01%
550
– –
LEVI icon
172
Levi Strauss
LEVI
$9.53B
$11K ﹤0.01%
500
– –
UBER icon
173
Uber
UBER
$139B
$11K ﹤0.01%
+240
New +$10.2K
UTG icon
174
Reaves Utility Income Fund
UTG
$3.58B
$11K ﹤0.01%
300
– –
WMT icon
175
Walmart Inc
WMT
$894B
$11K ﹤0.01%
300
– –
5 6
7
8 9

Similar funds

SAM
Stansberry Asset Management Westlake, Texas $973M AUM 21.39% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
TCCM
Two Creeks Capital Management New York $974M AUM 2.54% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
ADIC
Abu Dhabi Investment Council Abu Dhabi, United Arab Emirates $975M AUM
MGCM
Mane Global Capital Management New York $971M AUM 58.5% 1-Year Est. Return
LOIM
Liberty One Investment Management Libertyville, Illinois $970M AUM 12.15% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return

RPG Investment Advisory's Q2 2019 Portfolio in Review

As of Q2 2019, RPG Investment Advisory held 301 positions worth $425M, down 0.59% from $427M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

RPG Investment Advisory's Q2 2019 filing shows 12 new, 53 increased, 74 reduced and 36 closed positions. Its largest new stake was Bristol-Myers Squibb: 158,451 shares worth $7.22M. The largest sale was Celgene Corp, an estimated $6.56M.

By sector, the portfolio is most concentrated in Energy at 11% of assets, down from 11% a quarter earlier, followed by Technology and Consumer Discretionary.

  • RPG Investment Advisory's largest Q2 2019 buy was Bristol-Myers Squibb: 158,451 shares worth $7.22M.
  • RPG Investment Advisory added most to SPDR Gold Trust in Q2 2019, an estimated $7.45M increase.
  • RPG Investment Advisory's biggest Q2 2019 reduction was Starbucks, cutting an estimated $6.48M.
  • RPG Investment Advisory fully exited Celgene Corp in Q2 2019, selling an estimated $6.56M.
  • RPG Investment Advisory's ten largest holdings make up 26% of its $425M portfolio in Q2 2019.
  • RPG Investment Advisory opened 12 new positions and closed 36 in Q2 2019.
  • RPG Investment Advisory's portfolio value fell 0.59% quarter-over-quarter to $425M.

Based on RPG Investment Advisory's 13F filing for Q2 2019, filed 10 Jul 2019.